NCT02026206View on ClinicalTrials.gov

Low-level Light Therapy for Primary Dysmenorrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Primary Dysmenorrhea
Interventions
DEVICE

low-level light therapy

we used a skin-adhesive LLLT device called the Color DNA-WSF (Color Seven Co., Seoul, Korea) which consists of body for power supply and two microprocessor-controlled light-emitting diodes. We selected two acupuncture points, conception vessel 4 (CV4; Guanyuan) and CV6 (Qihai), for treating dysmenorrhea. The participants attached the skin-adhesive LLLT device probes to both acupuncture points according to treatment schedule.

DEVICE

Placebo

we used a placebo skin-adhesive LLLT device called the Color DNA-WSF (Color Seven Co., Seoul, Korea) which consists of body for power supply and two microprocessor-controlled light-emitting diodes. We selected two acupuncture points, conception vessel 4 (CV4; Guanyuan) and CV6 (Qihai), for treating dysmenorrhea. The participants attached the placebo skin-adhesive LLLT device probes to both acupuncture points according to treatment schedule.

Trial Locations (2)

570-711

Wonkwang University Hospital, Iksan

626-770

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University

OTHER

NCT02026206 - Low-level Light Therapy for Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter